Cross Country Healthcare (NASDAQ:CCRN) Given “Market Perform” Rating at JMP Securities

Cross Country Healthcare (NASDAQ:CCRNGet Free Report)‘s stock had its “market perform” rating reiterated by stock analysts at JMP Securities in a research report issued on Thursday,Benzinga reports.

CCRN has been the topic of a number of other reports. William Blair lowered Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 4th. Benchmark cut Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. Truist Financial increased their price objective on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the company a “hold” rating in a research report on Thursday, December 5th. Barrington Research reissued a “market perform” rating on shares of Cross Country Healthcare in a report on Tuesday, December 10th. Finally, StockNews.com began coverage on Cross Country Healthcare in a report on Friday, January 31st. They set a “hold” rating for the company. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat, Cross Country Healthcare has an average rating of “Hold” and a consensus target price of $18.54.

Get Our Latest Analysis on CCRN

Cross Country Healthcare Stock Performance

Shares of NASDAQ CCRN traded down $0.01 during midday trading on Thursday, reaching $18.22. 37,147 shares of the company traded hands, compared to its average volume of 441,474. The stock’s 50-day simple moving average is $17.55 and its 200-day simple moving average is $14.86. Cross Country Healthcare has a 12 month low of $9.58 and a 12 month high of $21.41. The firm has a market cap of $597.82 million, a PE ratio of -364.23, a PEG ratio of 3.35 and a beta of 0.44.

Hedge Funds Weigh In On Cross Country Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of CCRN. Truvestments Capital LLC bought a new stake in Cross Country Healthcare during the 3rd quarter worth approximately $39,000. Plato Investment Management Ltd bought a new stake in Cross Country Healthcare in the fourth quarter valued at approximately $46,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Cross Country Healthcare during the third quarter valued at approximately $49,000. Point72 DIFC Ltd bought a new position in shares of Cross Country Healthcare in the third quarter worth approximately $52,000. Finally, Gladius Capital Management LP increased its stake in shares of Cross Country Healthcare by 83.4% in the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock worth $54,000 after buying an additional 1,812 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Articles

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.